peptide therapy bpc 157 BPC-157 BPC-157 Peptide Therapy | New

Indications: Pernicious anemia, malabsorption (e.g., Crohns, gastric bypass), or rapid correction

Adding 3mL creates a 3.33mg/mL solution

Use the SeekPeptides reconstitution calculator to eliminate human error from this process

It is one of the eight B vitamins

Phase 2 trials confirmed no changes to fasting glucose, insulin, or IGF-1 levels after 12 weeks of AOD-9604 dosing, making it mechanistically distinct from full growth hormone therapy

As a cyclic disulfide-containing peptide, AOD-9604 warrants standard handling considerations for cysteine-bearing sequences, including protection from oxidative and reductive conditions during reference-standard preparation, and storage of the lyophilizate under cool, dry, light-protected conditions to preserve analytical integrity